Finance Ministry presents three new investor facilitation packages to PM to boost investment climate    Egypt, Bahrain explore deeper cooperation on water resource management    Egypt condemns Israeli offensive in Gaza City, warns of grave regional consequences    Cairo University, Roche Diagnostics inaugurate automated lab at Qasr El-Ainy    Egypt expands medical, humanitarian support for Gaza patients    Egypt investigates disappearance of ancient bracelet from Egyptian Museum in Tahrir    Egypt launches international architecture academy with UNESCO, European partners    African trade ministers meet in Cairo to push forward with AfCFTA    Egypt's President, Pakistan's PM condemn Israeli attack on Qatar    Egypt signs MoUs with 3 European universities to advance architecture, urban studies    Madrid trade talks focus on TikTok as US and China seek agreement    Egypt wins Aga Khan Award for Architecture for Esna revival project    Egypt's gold prices hold steady on Sep. 15th    Egypt's Sisi, Qatar's Emir condemn Israeli strikes, call for Gaza ceasefire    Egypt condemns terrorist attack in northwest Pakistan    Egypt advances plans to upgrade historic Cairo with Azbakeya, Ataba projects    Egyptian pound ends week lower against US dollar – CBE    Egypt hosts G20 meeting for 1st time outside member states    Egypt to tighten waste rules, cut rice straw fees to curb pollution    Egypt seeks Indian expertise to boost pharmaceutical industry    Egypt prepares unified stance ahead of COP30 in Brazil    Egypt harvests 315,000 cubic metres of rainwater in Sinai as part of flash flood protection measures    Al-Sisi says any party thinking Egypt will neglect water rights is 'completely mistaken'    Egyptian, Ugandan Presidents open business forum to boost trade    Egypt's Sisi, Uganda's Museveni discuss boosting ties    Egypt's Sisi warns against unilateral Nile measures, reaffirms Egypt's water security stance    Greco-Roman rock-cut tombs unearthed in Egypt's Aswan    Egypt reveals heritage e-training portal    Sisi launches new support initiative for families of war, terrorism victims    Egypt expands e-ticketing to 110 heritage sites, adds self-service kiosks at Saqqara    Palm Hills Squash Open debuts with 48 international stars, $250,000 prize pool    On Sport to broadcast Pan Arab Golf Championship for Juniors and Ladies in Egypt    Golf Festival in Cairo to mark Arab Golf Federation's 50th anniversary    Germany among EU's priciest labour markets – official data    Paris Olympic gold '24 medals hit record value    A minute of silence for Egyptian sports    Russia says it's in sync with US, China, Pakistan on Taliban    It's a bit frustrating to draw at home: Real Madrid keeper after Villarreal game    Shoukry reviews with Guterres Egypt's efforts to achieve SDGs, promote human rights    Sudan says countries must cooperate on vaccines    Johnson & Johnson: Second shot boosts antibodies and protection against COVID-19    Egypt to tax bloggers, YouTubers    Egypt's FM asserts importance of stability in Libya, holding elections as scheduled    We mustn't lose touch: Muller after Bayern win in Bundesliga    Egypt records 36 new deaths from Covid-19, highest since mid June    Egypt sells $3 bln US-dollar dominated eurobonds    Gamal Hanafy's ceramic exhibition at Gezira Arts Centre is a must go    Italian Institute Director Davide Scalmani presents activities of the Cairo Institute for ITALIANA.IT platform    







Thank you for reporting!
This image will be automatically disabled when it gets reported by several people.



HEALTH MATTERS: Can an Aspirin a day keep the doctor away?
Published in Daily News Egypt on 18 - 05 - 2007

Years ago, while I was studying pharmacology, aspirin was viewed as a useful drug for relief from pain, fever and inflammation, and for preventing heart attacks and strokes. However, its potentially serious side effects of causing stomach bleeding or ulcers and tinnitus (ringing in the ears) rendered aspirin a relatively toxic drug. At that time, one of my professors told me: "If Aspirin was just coming onto the market today, it would not be approved for human use. Whether or not this is true is debatable.
The test of time, however, has proven Aspirin to be an indispensable drug saving millions of lives and preventing a range of diseases including various cancers.
Bowel cancer, often called a silent killer because of its apparent lack of symptoms, is the second most common cancer in Europe and the US. It's on the increase in developing countries, such as Egypt, due to the increasingly more Westernized diet. Screening is often carried out too late; and in the UK, approximately half of those diagnosed will die of the disease. Research published last week in the Lancet, suggests that a daily dose of 300mg or more of Aspirin over a prolonged period may protect against bowel cancer.
The study showed that taking at least 300mg Aspirin a day for five years reduced the subsequent incidence of bowel cancer by 37 percent, and by 74 percent during the ten to 15 years after treatment. This protective effect was consistent regardless of age, sex, race or country of origin and was also seen in people who had a close family relative with bowel cancer, which normally increases their risk of contracting the disease by 2-4 times.
The Lancet study confirms the results of several previous studies attributing Aspirin to bowel cancer prevention. Other cancers, such as those of the throat, mouth and esophagus, were also found to be dramatically lowered in studies where Aspirin was taken regularly for at least five years. Furthermore, a recent American study found that aspirin reduced the incidence of a range of cancers including breast, ovarian and prostrate cancer as well as boosting survival rates of those who did contract the disease.
Anyone who has experienced a heart attack or stroke, will know that one of the first drugs prescribed by the physician will be Aspirin. It lowers the risk of heart attacks and strokes in high-risk patients by up to a third.
Aspirin is also sometimes used as preventative measure against deep vein thrombosis in those people most at risk (such as after a major operation).
But Aspirin's protective effects are not limited to preventing cancer and blood clots. Recent evidence suggests that Aspirin may also reduce the incidence of Alzheimer's disease.
How does aspirin work?
Aspirin (primarily composed of salicylic acid) inhibits substances involved in inflammation and platelets (blood cells) clotting. Aspirin prevents heart attacks by reducing the inflammation in the arteries that would cause it to harden, and reducing the occurrence of blood clots. Aspirin also inhibits key enzymes in the inflammatory process, one of which is cyclo oxygenase 2 (COX 2); COX2 levels are increased in many tumors and inhibiting this enzyme may lead to cancer cell death or suppress cancer cell development. Alzheimer's has an inflammatory component and aspirin may reduce its development through its inhibition of COX2.
Should we take a daily dose of Aspirin to prevent cancer and degenerative disease and if so, at what dose?
This is not an easy question to answer as Aspirin's serious side effects warrant a cautionary stance. As well as stomach bleeding and ulcers, long-term treatment with aspirin can lead to other serious side effects including prolonged bleeding and kidney damage. Aspirin is also contraindicated for children or teenagers as it can lead to the potentially fatal Reye s syndrome which affects the brain and liver, and for pregnant women as it can cause miscarriage.
That said, many heart patients take 'baby' Aspirin, or 81 mg, which has been proven to be just as effective in protecting against heart disease as 300mg dose, but causes less internal bleeding.
Some scientists even believe that people at high risk for bowel cancer (and perhaps other cancers and Alzheimer's) should consider taking a daily dose of aspirin under supervision of their physician.
Many everyday vegetables, fruits and herbs contain high amounts of salicylic acid and eating more of these may be an alternative option to warding off diseases.
Meanwhile, a new enzyme (COX 3) involved in inflammation has just been discovered to reside in the brain and heart that is also inhibited by aspirin, and will no doubt tell us more about the benefits of this fascinating drug.
May El Meleigyholds a Ph.D in Immunology (London School of Hygiene and Tropical Medicine), an MSc in Toxicology/Pathology (Royal Postgraduate Medical School, London) and a BSc in Pharmacology (University College London). May is a medical and health journalist, and is a regular contributor to the British Medical Journal, Lancet, and WHO bulletin. May also produces health programs for Egyptian Television.


Clic here to read the story from its source.